Wg. Mayhan et I. Rubinstein, EFFECTS OF ENDOTHELIN RECEPTOR ANTAGONISTS ON BRADYKININ-INDUCED INCREASES IN MACROMOLECULAR EFFLUX, Inflammation, 18(6), 1994, pp. 633-644
The goal of this study was to determine the effects of endothelin rece
ptor antagonists on agonist-induced increases in macromolecular extrav
asation in the hamster cheek pouch in vivo. We used intravital fluores
cent microscopy and fluorescein isothiocyanate dextran (FITC-dextran;
mol wt = 70 K) to examine extravasation from postcapillary venules in
response to bradykinin and endothelin before and following application
of inhibitors of endothelin receptors (ET(AB) and ET(A)). Increases i
n extravasation of macromolecules were quantitated by counting the num
ber of venular leaky sites. Bradykinin (0.5 and 1.0 mu M) and endothel
in-1 (0.01 and 0.1 nM) produced a dose-related increase in the number
of venular leaky sites and superfusion of PD 142893 (ET(AB) antagonist
), and PD 147953 and BQ-123 (ET(A) antagonists) significantly decrease
d bradykinin- and endothelin-induced responses. Addition of calcium to
the superfusate restored bradykinin-induced increases in venular leak
y sites in the presence of endothelin receptor antagonism. Thus, the f
indings of the present study suggest that endothelin receptor antagoni
sts abrogate bradykinin- and endothelin-induced increases in macromole
cular efflux from postcapillary venules. The mechanism for the effects
of endothelin receptor antagonists appears to be related to inhibitio
n of the ET(A) receptor which, in turn, alters the mobilization of cal
cium across venular endothelium.